Overview
Morie Gertz is a Hematologist in Rochester, Minnesota. Dr. Gertz has been practicing medicine for over 44 years is highly rated in 24 conditions, according to our data. His top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Waldenstrom Macroglobulinemia, Bone Marrow Transplant, and Tissue Biopsy.
His clinical research consists of co-authoring 740 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 1st St SW, Rochester, MN 55905
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
MN - Cancer Hematology
Ayalew Tefferi is a Hematologist in Rochester, Minnesota. Dr. Tefferi has been practicing medicine for over 44 years is highly rated in 23 conditions, according to our data. His top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenectomy, and Bone Marrow Transplant.
MN - Cancer Hematology
Angela Dispenzieri is a Hematologist in Rochester, Minnesota. Dr. Dispenzieri is highly rated in 24 conditions, according to our data. Her top areas of expertise are Primary Amyloidosis, POEMS Syndrome, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
MN - Cancer
Stephen Ansell is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Ansell is highly rated in 25 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.
Frequently Asked Questions about Dr. Morie Gertz
How do I make an appointment with Dr. Morie Gertz?
You can book an appointment with Dr. Morie Gertz by calling their office at 507-229-0068. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Morie Gertz a top-rated expert for Primary Amyloidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Morie Gertz is classified as an Elite expert for Primary Amyloidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Morie Gertz specialize in?
While Dr. Morie Gertz is a Hematology, they have specific expertise in Primary Amyloidosis, Multiple Myeloma, and Waldenstrom Macroglobulinemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Morie Gertz participate in research or clinical trials?
Yes. Dr. Morie Gertz has published 740 articles and abstracts on conditions like Primary Amyloidosis. You can view a list of Dr. Morie Gertz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Morie Gertz accept my insurance?
Dr. Morie Gertz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 507-229-0068 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Autoimmune Hemolytic Anemia
- Bone Marrow TransplantDr. Gertz isElite. Learn about Bone Marrow Transplant.
- Cardiac AmyloidosisDr. Gertz isElite. Learn about Cardiac Amyloidosis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Gertz isElite. Learn about Multiple Myeloma.
- PlasmacytomaDr. Gertz isElite. Learn about Plasmacytoma.
- Advanced
- AnemiaDr. Gertz isAdvanced. Learn about Anemia.
- Cerebral Amyloid AngiopathyDr. Gertz isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- CryoglobulinemiaDr. Gertz isAdvanced. Learn about Cryoglobulinemia.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- HemolysisDr. Gertz isAdvanced. Learn about Hemolysis.
- Hemolytic AnemiaDr. Gertz isAdvanced. Learn about Hemolytic Anemia.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Gertz isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Gertz isExperienced. Learn about Acute Myelomonocytic Leukemia.
- AgranulocytosisDr. Gertz isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Gertz isExperienced. Learn about B-Cell Lymphoma.